Shopping Cart
- Remove All
Your shopping cart is currently empty
Iladatuzumab vedotin (DCDS-0780A) is an ADC compound targeting CD79b, conjugated with the cytotoxic drug MMAE through a cleavable dipeptide linker mc-val-cit-PABC, used in the study of non-Hodgkin lymphoma.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $1,970 | In Stock | |
| 5 mg | $4,280 | In Stock |
| Description | Iladatuzumab vedotin (DCDS-0780A) is an ADC compound targeting CD79b, conjugated with the cytotoxic drug MMAE through a cleavable dipeptide linker mc-val-cit-PABC, used in the study of non-Hodgkin lymphoma. |
| Synonyms | DCDS-0780A, DCDS0780A |
| Cas No. | 1906205-77-3 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.